ACTRN12612000985886
Completed
未知
A randomised controlled trial to evaluate whether a proven internet-delivered Cognitive Behavioural Therapy (CBT) treatment program for insomnia can improve the outcomes of standard treatment of depression in men.
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Depression
- Sponsor
- The University of Sydney
- Enrollment
- 80
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •All participants must meet the following inclusion criteria: (a) currently meet the criteria for at least minor depression (defined as screening positive (8\+) on the Quick Inventory of Depression Symptomology (QIDS) and at clinical interview by having one of the two cardinal symptoms of Major Depressive Disorder (MDD) and at least two other symptoms of depression for two weeks or more (four symptoms minimum in total)); and (b) self report insomnia symptoms above the threshold (8\+) Insomnia Severity Index (ISI).
Exclusion Criteria
- •We will exclude participants if: (a) they have a history of psychosis, or hypo/manic episodes; (b) have a current substance dependence; (c) have a score of \<24 on the Mini Mental State Examination; all as determined by the psychiatrist clinical interview; (d) are a rotating shift worker with overnight shifts or transmeridian travel \>2 hours in the past month with inadequate time to readjust prior to trial commencement; (e) have all the criteria for Restless Legs Syndrome as defined using the RLS\-12 at screening; (f) are at high risk for obstructive sleep apnea (OSA) as defined by the Berlin Questionnaire or have been treated for OSA.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Evaluation of an internet-delivered program for risky alcohol use in older adultsHazardous and harmful alcohol useMental Health - AddictionPublic Health - Health service researchPublic Health - Health promotion/educationACTRN12621000292875SW Sydney888
Completed
Not Applicable
Zoledronate to prevent bone loss in acute multiple sclerosisMultiple sclerosisNervous System DiseasesISRCTN87039596orth Bristol NHS Trust (UK)40
Completed
Not Applicable
Risedronate for the prevention of bone loss after steroid therapy for a flare-up in inflammatory bowel diseaseInflammatory bowel disease (ulcerative colitis and Crohn's disease)Digestive SystemNoninfective inflammatory bowel diseaseISRCTN93280043niversity Hospitals Bristol NHS Foundation Trust (UK)100
Completed
Not Applicable
A randomized controlled trial on effects of Cryo/Cuff in early rehabilitation of total knee arthroplastyDegenerative knee joint osteoarthritisMusculoskeletal DiseasesOsteoarthritisISRCTN12615549Peking Union Medical College Hospital98
Terminated
Not Applicable
se of Physiological Techniques in Heart Failure ManagementACTRN12609000442202ational Health and Medical Research Council360